Rubin, M. R., de Boer, I. H., Backlund, J.-Y. C., Arends, V., Gubitosi-Klug, R., Wallia, A., Sinha Gregory, N., Barnie, A., Burghardt, A. J., Lachin, J. M., Braffett, B. H., & Schwartz, A. V. (2022). Biochemical Markers of Bone Turnover in Older Adults With Type 1 Diabetes. The Journal of Clinical Endocrinology & Metabolism, 107(6), e2405–e2416. https://doi.org/10.1210/clinem/dgac099

Gregory, G. P., Kumar, S., Wang, D., Mahadevan, D., Walker, P., Wagner-Johnston, N., Escobar, C., Bannerji, R., Bhutani, D., Chang, J., Hernandez-Ilizaliturri, F. J., Klein, A., Pagel, J. M., Rybka, W., Yee, A. J., Mohrbacher, A., Huang, M., Farooqui, M., Marinello, P., & Quach, H. (2022). Pembrolizumab plus dinaciclib in patients with hematologic malignancies: the phase 1b KEYNOTE-155 study. Blood Advances, 6(4), 1232–1242. https://doi.org/10.1182/bloodadvances.2021005872

Efficace, F., Cottone, F., Sparano, F., Caocci, G., Vignetti, M., & Chakraborty, R. (2022). Patient-Reported Outcomes in Randomized Controlled Trials of Patients with Multiple Myeloma: A Systematic Literature Review of Studies Published Between 2014 and 2021. Clinical Lymphoma Myeloma and Leukemia, 22(7), 442–459. https://doi.org/10.1016/j.clml.2022.01.009

Tokgozoglu, L., Orringer, C., Ginsberg, H. N., & Catapano, A. L. (2022). The year in cardiovascular medicine 2021: dyslipidaemia. European Heart Journal, 43(8), 807–817. https://doi.org/10.1093/eurheartj/ehab875

Labib, A., August, E., Agerstrand, C., Frenckner, B., Laufenberg, D., Lavandosky, G., Fajardo, C., Gluck, J. A., & Brodie, D. (2022). Extracorporeal Life Support Organization Guideline for Transport and Retrieval of Adult and Pediatric Patients with ECMO Support. ASAIO Journal, 68(4), 447–455. https://doi.org/10.1097/mat.0000000000001653

Giustina, A., & Bilezikian, J. P. (2022). Revisiting the endocrine and metabolic manifestations of COVID-19 two years into the pandemic. Reviews in Endocrine and Metabolic Disorders, 23(2), 133–136. https://doi.org/10.1007/s11154-022-09716-x

Duran, A. T., Romero, E., & Diaz, K. M. (2022). Is Sedentary Behavior a Novel Risk Factor for Cardiovascular Disease? Current Cardiology Reports, 24(4), 393–403. https://doi.org/10.1007/s11886-022-01657-w

Pabon, M., Cheng, S., Altin, S. E., Sethi, S. S., Nelson, M. D., Moreau, K. L., Hamburg, N., & Hess, C. N. (2022). Sex Differences in Peripheral Artery Disease. Circulation Research, 130(4), 496–511. https://doi.org/10.1161/circresaha.121.320702

DesJardin, J. T., Chikwe, J., Hahn, R. T., Hung, J. W., & Delling, F. N. (2022). Sex Differences and Similarities in Valvular Heart Disease. Circulation Research, 130(4), 455–473. https://doi.org/10.1161/circresaha.121.319914

Suarez, L., Kim, J., Freedberg, D. E., & Lebwohl, B. (2022). Risk of Healthcare-Associated Clostridioides difficile Infection During Pandemic Preparation: A Retrospective Cohort Study. Gastro Hep Advances, 1(1), 8–11. https://doi.org/10.1016/j.gastha.2021.08.005

Summers, R. L., Pasaje, C. F. A., Pisco, J. P., Striepen, J., Luth, M. R., Kumpornsin, K., Carpenter, E. F., Munro, J. T., Lin, D., Plater, A., Punekar, A. S., Shepherd, A. M., Shepherd, S. M., Vanaerschot, M., Murithi, J. M., Rubiano, K., Akidil, A., Ottilie, S., Mittal, N., … Lukens, A. K. (2022). Chemogenomics identifies acetyl-coenzyme A synthetase as a target for malaria treatment and prevention. Cell Chemical Biology, 29(2), 191-201.e8. https://doi.org/10.1016/j.chembiol.2021.07.010

DeFilippis, E. M., Beale, A., Martyn, T., Agarwal, A., Elkayam, U., Lam, C. S. P., & Hsich, E. (2022). Heart Failure Subtypes and Cardiomyopathies in Women. Circulation Research, 130(4), 436–454. https://doi.org/10.1161/circresaha.121.319900

Kanter, J., Walters, M. C., Krishnamurti, L., Mapara, M. Y., Kwiatkowski, J. L., Rifkin-Zenenberg, S., Aygun, B., Kasow, K. A., Pierciey, F. J., Bonner, M., Miller, A., Zhang, X., Lynch, J., Kim, D., Ribeil, J.-A., Asmal, M., Goyal, S., Thompson, A. A., & Tisdale, J. F. (2022). Biologic and Clinical Efficacy of LentiGlobin for Sickle Cell Disease. New England Journal of Medicine, 386(7), 617–628. https://doi.org/10.1056/nejmoa2117175

Troy, C., Gill, B. J. A., Miller, M. L., Hickman, R. A., Canoll, P., Zacharoulis, S., Feldstein, N. A., & Bruce, J. N. (2022). Adenocarcinoma Arising in a Yolk Sac Tumor of the Pineal Gland. Journal of Neuropathology & Experimental Neurology, 81(4), 291–295. https://doi.org/10.1093/jnen/nlac002

Emilsson, L., Radkiewicz, C., Semrad, C. E., Joshi, A. D., & Ludvigsson, J. F. (2022). Gall Bladder Disease and the Risk of Small Bowel Cancer—Results from a Nationwide Swedish Cohort Study. Cancers, 14(3), 469. https://doi.org/10.3390/cancers14030469

Joyce, M. G., King, H. A. D., Elakhal-Naouar, I., Ahmed, A., Peachman, K. K., Macedo Cincotta, C., Subra, C., Chen, R. E., Thomas, P. V., Chen, W.-H., Sankhala, R. S., Hajduczki, A., Martinez, E. J., Peterson, C. E., Chang, W. C., Choe, M., Smith, C., Lee, P. J., Headley, J. A., … Modjarrad, K. (2022). A SARS-CoV-2 ferritin nanoparticle vaccine elicits protective immune responses in nonhuman primates. Science Translational Medicine, 14(632). https://doi.org/10.1126/scitranslmed.abi5735

Dridi, H., Santulli, G., Gambardella, J., Jankauskas, S. S., Yuan, Q., Yang, J., Reiken, S., Wang, X., Wronska, A., Liu, X., Lacampagne, A., & Marks, A. R. (2022). IP3 receptor orchestrates maladaptive vascular responses in heart failure. Journal of Clinical Investigation, 132(4). https://doi.org/10.1172/jci152859

Grady, K. L., Andrei, A., Elenbaas, C., Warzecha, A., Baldridge, A., Kao, A., Spertus, J. A., Pham, D., Dew, M. A., Hsich, E., Cotts, W., Hartupee, J., Pamboukian, S. V., Pagani, F. D., Petty, M., Lampert, B., Johnson, M., Murray, M., Takeda, K., … Yancy, C. (2022). Health‐Related Quality of Life in Older Patients With Advanced Heart Failure: Findings From the SUSTAIN‐IT Study. Journal of the American Heart Association, 11(4). https://doi.org/10.1161/jaha.121.024385

Viny, A. D. (2021). DNMT3A-Mutant Leukemia Cells Primed to “Fork It Over” under DNA Damage. Clinical Cancer Research, 28(4), 573–575. https://doi.org/10.1158/1078-0432.ccr-21-3949

Windham, B. G., Parker, S. B., Zhu, X., Gabriel, K. P., Palta, P., Sullivan, K. J., Parker, K. G., Knopman, D. S., Gottesman, R. F., Griswold, M. E., & Mosley, T. H. (2022). Endurance and gait speed relationships with mild cognitive impairment and dementia. Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring, 14(1). Portico. https://doi.org/10.1002/dad2.12281

Lee, K. E., Bender, D. A., Koutcher, L. D., Hyde, B., Hur, C., Faye, A. S., & Cheng, S. K. (2021). Risk of corticosteroid treatment and hospitalization after checkpoint inhibitor and radiation therapy in patients with cancer. Cancer, 128(4), 819–827. Portico. https://doi.org/10.1002/cncr.33975

Weintraub, W. S., Bhatt, D. L., Zhang, Z., Dolman, S., Boden, W. E., Bress, A. P., King, J. B., Bellows, B. K., Tajeu, G. S., Derington, C. G., Johnson, J., Andrade, K., Steg, P. G., Miller, M., Brinton, E. A., Jacobson, T. A., Tardif, J.-C., Ballantyne, C. M., & Kolm, P. (2022). Cost-effectiveness of Icosapent Ethyl for High-risk Patients With Hypertriglyceridemia Despite Statin Treatment. JAMA Network Open, 5(2), e2148172. https://doi.org/10.1001/jamanetworkopen.2021.48172

Meric-Bernstam, F., Sweis, R. F., Hodi, F. S., Messersmith, W. A., Andtbacka, R. H. I., Ingham, M., Lewis, N., Chen, X., Pelletier, M., Chen, X., Wu, J., Dubensky, T. W., McWhirter, S. M., Müller, T., Nair, N., & Luke, J. J. (2021). Phase I Dose-Escalation Trial of MIW815 (ADU-S100), an Intratumoral STING Agonist, in Patients with Advanced/Metastatic Solid Tumors or Lymphomas. Clinical Cancer Research, 28(4), 677–688. https://doi.org/10.1158/1078-0432.ccr-21-1963

Murphy, C. G., Nishikawa, M. S., Char, S. T., Nemeth, S. K., Parekh, M., Bulman, W. A., Wu, C., Neuberg, G. W., Louh, I. K., Schluger, N. W., Prager, K. M., Fischkoff, K. N., & Burkart, K. M. (2022). In COVID-19 Patients Who Suffer In-Hospital Cardiac Arrest, Cardiopulmonary Resuscitation Outcomes May Be Impacted by Arrest Etiology and Local Pandemic Conditions. Critical Care Explorations, 4(2), e0605. https://doi.org/10.1097/cce.0000000000000605

Hahn, R. T., Badano, L. P., Bartko, P. E., Muraru, D., Maisano, F., Zamorano, J. L., & Donal, E. (2022). Tricuspid regurgitation: recent advances in understanding pathophysiology, severity grading and outcome. European Heart Journal - Cardiovascular Imaging, 23(7), 913–929. https://doi.org/10.1093/ehjci/jeac009

Mato, A. R., Davids, M. S., Sharman, J., Roeker, L. E., Kay, N., Kater, A. P., Rogers, K., Thompson, M. C., Rhodes, J., Goy, A., Skarbnik, A., Schuster, S. J., Tam, C. S., Eyre, T. A., O’Brien, S., Nabhan, C., Lamanna, N., Sun, C., Shadman, M., … Woyach, J. A. (2021). Recognizing Unmet Need in the Era of Targeted Therapy for CLL/SLL: “What’s Past Is Prologue” (Shakespeare). Clinical Cancer Research, 28(4), 603–608. https://doi.org/10.1158/1078-0432.ccr-21-1237

Shabbir, A., Kojadinovic, A., Gidfar, S., & Mundi, P. S. (2022). Extranodal Diffuse Large B-Cell Lymphoma of Bone and Soft Tissue Presenting With Marked Lymphedema and Hypercalcemia. Cureus. https://doi.org/10.7759/cureus.22025

Chiarito, M., Baber, U., Cao, D., Sharma, S. K., Dangas, G., Angiolillo, D. J., Briguori, C., Cohen, D. J., Dudek, D., Džavík, V., Escaned, J., Gil, R., Hamm, C. W., Henry, T., Huber, K., Kastrati, A., Kaul, U., Kornowski, R., Krucoff, M., … Mehran, R. (2022). Ticagrelor Monotherapy After PCI in High-Risk Patients With Prior MI. JACC: Cardiovascular Interventions, 15(3), 282–293. https://doi.org/10.1016/j.jcin.2021.11.005

Olazagasti, C., Ehrlich, M., Kohn, N., Aviles, K., Hoilett, A., & Seetharamu, N. (2022). Missed Opportunities? An Observational Analysis of Lung Cancer Screening Utilization Amongst Patients With Lung Cancer. Cancer Control, 29. https://doi.org/10.1177/10732748221077959

Lauren, B. N., Lim, F., Krikhely, A., Taveras, E. M., Woo Baidal, J. A., Bellows, B. K., & Hur, C. (2022). Estimated Cost-effectiveness of Medical Therapy, Sleeve Gastrectomy, and Gastric Bypass in Patients With Severe Obesity and Type 2 Diabetes. JAMA Network Open, 5(2), e2148317. https://doi.org/10.1001/jamanetworkopen.2021.48317

Sahm, V., Maurer, C., Baumeister, T., Anand, A., Strangmann, J., Schmid, R. M., Wang, T. C., & Quante, M. (2022). Telomere shortening accelerates tumor initiation in the L2-IL1B mouse model of Barrett esophagus and emerges as a possible biomarker. Oncotarget, 13(1), 347–359. https://doi.org/10.18632/oncotarget.28198

Raverdy, V., Cohen, R. V., Caiazzo, R., Verkindt, H., Petry, T. B. Z., Marciniak, C., Legendre, B., Bauvin, P., Chatelain, E., Duhamel, A., Drumez, E., Oukhouya-Daoud, N., Chetboun, M., Baud, G., Ahlqvist, E., Wierup, N., Asplund, O., Laferrère, B., Groop, L., & Pattou, F. (2022). Data-driven subgroups of type 2 diabetes, metabolic response, and renal risk profile after bariatric surgery: a retrospective cohort study. The Lancet Diabetes & Endocrinology, 10(3), 167–176. https://doi.org/10.1016/s2213-8587(22)00005-5

Shivashankar, R., Sharma, B., Moran, A. E., & Pathni, A. K. (2021). Validation of a Practical Approach to Blood Pressure Measurement: Secondary Analysis of Data from a Nationally Representative Survey in India. Global Heart, 16(1). https://doi.org/10.5334/gh.1085

Hakim, S., & Sethi, A. (2022). Value of Endoscopic Ultrasonography in Evaluating Unexplained Isolated Common Bile Duct Dilation on Imaging. Clinical Endoscopy, 55(1), 47–48. https://doi.org/10.5946/ce.2022.029

Cerci, R. J., Vitola, J. V., Paez, D., Zuluaga, A., Bittencourt, M. S., Sierra-Galan, L. M., Carrascosa, P., Campisi, R., Gutierrez-Villamil, C., Peix, A., Chambers, D., Velez, M. S., Alvarado, C. M. G., Ventura, A. C. F., Maldonado, A., Castanos, A. P., Diaz, T. C., Herrera, Y., Vasquez, M. C., … Einstein, A. J. (2021). O Impacto da COVID-19 no Diagnóstico de Doenças Cardíacas na América Latina Uma Subanálise do INCAPS COVID. Arquivos Brasileiros de Cardiologia. https://doi.org/10.36660/abc.20210388

Nair, M. S., Huang, Y., Fidock, D. A., Towler, M. J., & Weathers, P. J. (2022). Artemisia annua L. hot-water extracts show potent activity in vitro against Covid-19 variants including delta. Journal of Ethnopharmacology, 284, 114797. https://doi.org/10.1016/j.jep.2021.114797

Moy, R. H., Walch, H. S., Mattar, M., Chatila, W. K., Molena, D., Strong, V. E., Tang, L. H., Maron, S. B., Coit, D. G., Jones, D. R., Hechtman, J. F., Solit, D. B., Schultz, N., de Stanchina, E., & Janjigian, Y. Y. (2022). Defining and Targeting Esophagogastric Cancer Genomic Subsets With Patient-Derived Xenografts. JCO Precision Oncology, 6. https://doi.org/10.1200/po.21.00242

Fusaro, M., Tondolo, F., Gasperoni, L., Tripepi, G., Plebani, M., Zaninotto, M., Nickolas, T. L., Ketteler, M., Aghi, A., Politi, C., La Manna, G., Brandi, M. L., Ferrari, S., Gallieni, M., Mereu, M. C., & Cianciolo, G. (2022). The Role of Vitamin K in CKD-MBD. Current Osteoporosis Reports, 20(1), 65–77. https://doi.org/10.1007/s11914-022-00716-z

Menghrajani, K., Gomez-Arteaga, A., Madero-Marroquin, R., Zhang, M.-J., Bo-Subait, K., Sanchez, J., Wang, H.-L., Aljurf, M., Assal, A., Bacher, V. U., Badawy, S. M., Bejanyan, N., Bhatt, V. R., Bredeson, C., Byrne, M., Castillo, P., Cerny, J., Chhabra, S., Ciurea, S. O., … Saber, W. (2022). Risk classification at diagnosis predicts post-HCT outcomes in intermediate-, adverse-risk, and KMT2A-rearranged AML. Blood Advances, 6(3), 828–847. https://doi.org/10.1182/bloodadvances.2021004881

Kishore, S. A., Bajwa, R., Van Doren, L., Wilkins, C., & O’Sullivan, G. J. (2022). Endovascular Management of Venous Thromboembolic Disease in the Oncologic Patient Population. Current Oncology Reports, 24(3), 351–362. https://doi.org/10.1007/s11912-022-01191-6

Small-Saunders, J. L., Hagenah, L. M., Wicht, K. J., Dhingra, S. K., Deni, I., Kim, J., Vendome, J., Gil-Iturbe, E., Roepe, P. D., Mehta, M., Mancia, F., Quick, M., Eppstein, M. J., & Fidock, D. A. (2022). Evidence for the early emergence of piperaquine-resistant Plasmodium falciparum malaria and modeling strategies to mitigate resistance. PLOS Pathogens, 18(2), e1010278. https://doi.org/10.1371/journal.ppat.1010278

Lopez-Bujanda, Z. A., Haffner, M. C., Chaimowitz, M. G., Chowdhury, N., Venturini, N. J., Patel, R. A., Obradovic, A., Hansen, C. S., Jacków, J., Maynard, J. P., Sfanos, K. S., Abate-Shen, C., Bieberich, C. J., Hurley, P. J., Selby, M. J., Korman, A. J., Christiano, A. M., De Marzo, A. M., & Drake, C. G. (2021). Castration-mediated IL-8 promotes myeloid infiltration and prostate cancer progression. Nature Cancer, 2(8), 803–818. https://doi.org/10.1038/s43018-021-00227-3

Salisbury, A. C., Kirtane, A. J., Ali, Z. A., Grantham, J. A., Lombardi, W. L., Yeh, R. W., Genereux, P., Allen, K. B., Brown, W. M., Nugent, K., Gosch, K. L., Karmpaliotis, D., Spertus, J. A., & Kandzari, D. E. (2022). The Outcomes of Percutaneous RevascularizaTIon for Management of SUrgically Ineligible Patients With Multivessel or Left Main Coronary Artery Disease (OPTIMUM) Registry: Rationale and Design. Cardiovascular Revascularization Medicine, 41, 83–91. https://doi.org/10.1016/j.carrev.2022.01.008

Huang, X., Liu, C., Kong, N., Xiao, Y., Yurdagul, A., Tabas, I., & Tao, W. (2022). Synthesis of siRNA nanoparticles to silence plaque-destabilizing gene in atherosclerotic lesional macrophages. Nature Protocols, 17(3), 748–780. https://doi.org/10.1038/s41596-021-00665-4

Fiuzat, M., Hamo, C. E., Butler, J., Abraham, W. T., DeFilippis, E. M., Fonarow, G. C., Lindenfeld, J., Mentz, R. J., Psotka, M. A., Solomon, S. D., Teerlink, J. R., Vaduganathan, M., Vardeny, O., McMurray, J. J. V., & O’Connor, C. M. (2022). Optimal Background Pharmacological Therapy for Heart Failure Patients in Clinical Trials. Journal of the American College of Cardiology, 79(5), 504–510. https://doi.org/10.1016/j.jacc.2021.11.033

Polizzotto, M. N., Nordwall, J., Babiker, A. G., Phillips, A., Vock, D. M., Eriobu, N., Kwaghe, V., Paredes, R., Mateu, L., Ramachandruni, S., Narang, R., Jain, M. K., Lazarte, S. M., Baker, J. V., Frosch, A. E. P., Poulakou, G., Syrigos, K. N., Arnoczy, G. S., McBride, N. A., … Lane, H. C. (2022). Hyperimmune immunoglobulin for hospitalised patients with COVID-19 (ITAC): a double-blind, placebo-controlled, phase 3, randomised trial. The Lancet, 399(10324), 530–540. https://doi.org/10.1016/s0140-6736(22)00101-5

Brener, M. I., Lurz, P., Hausleiter, J., Rodés-Cabau, J., Fam, N., Kodali, S. K., Rommel, K.-P., Muntané-Carol, G., Gavazzoni, M., Nazif, T. M., Pozzoli, A., Alessandrini, H., Latib, A., Biasco, L., Braun, D., Brochet, E., Denti, P., Lubos, E., Ludwig, S., … Hahn, R. T. (2022). Right Ventricular-Pulmonary Arterial Coupling and Afterload Reserve in Patients Undergoing Transcatheter Tricuspid Valve Repair. Journal of the American College of Cardiology, 79(5), 448–461. https://doi.org/10.1016/j.jacc.2021.11.031

Gilchrist, S. C., Hall, J. L., Khandelwal, A., Hidalgo, B., Aggarwal, B., Kinzy, C., Mallya, P., Conners, K., Stevens, L. M., Alger, H. M., Mehta, L., Wexler, L., Mega, J. L., Hernandez, A., Hayes, S. N., Mieres, J. H., Jessup, M., & Roger, V. L. (2022). Research Goes Red: Early Experience With a Participant-Centric Registry. Circulation Research, 130(3), 343–351. https://doi.org/10.1161/circresaha.121.320403

Shi, D. D., Guo, J. A., Hoffman, H. I., Su, J., Mino-Kenudson, M., Barth, J. L., Schenkel, J. M., Loeffler, J. S., Shih, H. A., Hong, T. S., Wo, J. Y., Aguirre, A. J., Jacks, T., Zheng, L., Wen, P. Y., Wang, T. C., & Hwang, W. L. (2022). Therapeutic avenues for cancer neuroscience: translational frontiers and clinical opportunities. The Lancet Oncology, 23(2), e62–e74. https://doi.org/10.1016/s1470-2045(21)00596-9

Kalani Roy, M., La Carpia, F., Cendali, F., Fernando, S., Moriconi, C., Wojczyk, B. S., Wang, L., Nemkov, T., Hod, E. A., & D’Alessandro, A. (2022). Irradiation Causes Alterations of Polyamine, Purine, and Sulfur Metabolism in Red Blood Cells and Multiple Organs. Journal of Proteome Research, 21(2), 519–534. https://doi.org/10.1021/acs.jproteome.1c00912